FDA Approves Amgen Drug for Persistently Deadly Form of Lung Cancer NYT: Science By: Gina Kolata 16 May 2024 at 16:59 The treatment is for patients with small cell lung cancer, which afflicts about 35,000 people in the U.S. a year. © Joe Buglewicz for The New York TimesMartha Warren, 65, of Westerly, R.I., found out last year that she had small cell lung cancer, and joined the tarlatamab clinical trial. She said she now feels as good as before her diagnosis.
Login
